Mayo Clinic Q&A: Cardiac Risks of Off-Label Drugs to Treat COVID-19

Everyone
  • 1 video | 15m 50s
Likes 36 Likes 36
A study published recently in Mayo Clinic Proceedings details information about potential cardiac side effects when using off-label drugs to treat COVID-19. Off-label means the drug has been approved by the Food and Drug Administration to treat a different condition. Some of the off-label drugs being used to treat COVID-19 have a risk of sudden cardiac arrest and death. (Published 04/08/2020)

IN THIS COURSE

  • 15m 51s
    On the Mayo Clinic Q&A podcast, Dr. Michael Ackerman, a Mayo Clinic genetic cardiologist and director of the  Windland Smith Rice Sudden Death Genomics Laboratory, explains how heart monitoring is important to identify at-risk patients. (Published 04/08/2020) FREE ACCESS

YOU MIGHT ALSO LIKE

Audiobook COVID-19 Miniseries: Mayo Clinic Q&A -- Sports Participation During COVID-19
Course Mayo Clinic Q&A: Looking Back and Moving Forward with Patient Care During COVID-19
Likes 22 Likes 22  
Course Mayo Clinic COVID-19 Live Webinar Series - March 15, 2021: Life After COVID
Likes 32 Likes 32  

PEOPLE WHO VIEWED THIS ALSO VIEWED THESE

Course Mayo Clinic Q&A: Emergency Medicine in the Time of COVID-19
Likes 35 Likes 35  
Course How Culture Impacts Communication
Likes 1474 Likes 1474  
Course Mayo Clinic COVID-19: Essentials for the Healthcare Worker
Likes 44 Likes 44